Irene Orlow: Publications

View a full listing of Irene Orlow: Publications’ journal articles.

  1. Polo-Silveira L, Dusza SW, Kentley J, Marchetti MA, Kurtansky NR, Bajaj S, Autuori I, Orlow I, Marghoob A, Halpern AC. Cutaneous Melanoma Risk Assessment among Individuals with a High-Risk Nevus Phenotype J Invest Dermatol. J Invest Dermatol. 2025 Nov;145(11):2919-2921.e2. doi: 10.1016/j.jid.2025.04.028. Epub 2025 May 13. PMID: 40373958 PMCID: PMC12230871 (available on 2026-05-13) DOI: 10.1016/j.jid.2025.04.028
  2. Zhang T,  Hua X,  Mohindroo C, Wang X,  Dutta D,  Liu J, Wang J, Li S, Antwi SO,  Arslan AA,  Beane Freeman LE,  Bracci PM, Canzian F,  Du M,  Gallinger S, Goodman PJ,  Katzke V, Kooperberg C,  Marchand LL,  Milne RL, Neale RE,  Patel AV,  Perdomo S, Shu XO, Visvanathan K,  Van Den Eeden SK,  White E, Zheng W,  Albanes D, Andreotti G,  Bamlet WR, Brennan P,  Buring JE, Chanock SJ,  Chen Y,  Darst B, Ferrari P, Giovannucci EL, Goggins M, Haiman C, Hassan M, Holly EA, Hung RJ, Jones MR, Kraft P,  Kurtz RC,  Malats N, Moore S,  Ng K, Oberg AL, Orlow I,  Peters U,  Porta M, Rabe KG,  Real FX, Rothman N,  Sánchez M-J,  Sesso HD, Silverman DT, Southey MC, Um C, Yarmolinsky J, Yu H, Yuan C, Zhong J, Wolpin BM,  Risch HA, Amundadottir LT,  Klein AP, Yu K,  Zhang H,  Stolzenberg-Solomon RZ. Different diabetes types and pancreatic ductal adenocarcinoma: A Mendelian randomization and pathway/gene-set analysis. Accepted in JNCI. 2025 October 7.
  3. Gibbs DC, Small BM, Autuori I, Leong SF, Ali E, Kenney J, Luo L, Kanetsky PA, Busam KJ, Cust AE, Anton-Culver H, Gallagher RP, Zanetti R, Rosso S, Sacchetto L, Edmiston SN, Conway K, Ollila DW, Begg CB, Berwick M, Orlow I, Thomas NE; GEM Study Group. Association of Inherited Genetic Variants with Multiple Primary Melanoma. Cancer Epidemiol Biomarkers Prev. 2025 May 2;34(5):805-814. doi: 10.1158/1055-9965.EPI-24-1442. PMID: 40036058. PMCID: PMC12067251.
  4. Wiggins C, Zhang, Q, Zhang, Y, Vand-Rajabpour F, Hanniford D, He L, Lu Y, Kenney JM, Sadeghi K, Argibay D, Orlow I, Busam K, Lezcano MC, Lee TK, Luo L, Gorlov I, Amos C, Ernstoff MS, Seshan VE, Cust AE, Wilmott JS, Scolyer RA, Mann G, Reiner AS, Kostrzewa CE, Nagore E, Funchain P, Ko J, Edmiston SN, Conway K, Googe PB, Ollila DW, Lee JE, Rees JR, Thompson CL, Gerstenblith M, Bosenberg M, Gould Rothberg BE, Osman I, Saenger Y, Reynolds AZ, Boyce T, Holmen S, Yan S, Brunsgaard E, Kuan PF, Bogner P, Thomas NE, Begg CB, Shen R, Berwick M, Shao Y, Polsky D, Hernando E. Tumor miRNA signatures associate with stage II/III melanoma patient outcomes. Clin Cancer Res. 2025 Oct 20.  doi: 10.1158/1078-0432.CCR-24-3785. Online ahead of print. PMID: 41114662. DOI: 10.1158/1078-0432.CCR-24-3785
  5. Ahles TA, Schofield E, Li Y, Ryan E, Orlow I, Patel SK, Traina T, Root JC. Cognitive function is mediated by deficit accumulation in older, long-term breast cancer survivors. J Cancer Surviv. 2024 Aug;18(4):1243-1251. doi: 10.1007/s11764-023-01365-6. PMID: 36964293. PMCID: PMC11803569. DOI: 10.1007/s11764-023-01365-6.